BIORRO

行业

饲料, 食品配料, 工业化学, 种子与遗传育种

主题

酶与生物催化, 畜禽生产与遗传育种, 益生菌与发酵菌种, 动物饲料与饲料添加剂

角色

服务 / 咨询 — “…ed biotechnology solutions, consulting, implementation of efficient technologies for businesses; emphasis on t…”

为何属于生物经济

BIORRO 是生物技术公司，供应农业和工业用酶产品、益生菌和饲料添加剂。

发现途径

AB Enzymes; Bioagra; [Rubric] Estonia · feed-additives; [Rubric] Estonia · inoculants

尚未被列为已评级方案的供应商。

• 2026-05 最新状态: 公司注册地址于2026年5月27日更新，经理已于2024年4月11日变更。 ↗ ↗ ↗
• 状态核查: active — Hosted Cosun Protein for talks on a faba-bean protein plant in Lithuania (2025-07).
• 2025-07-09 Field visit and business talks with Cosun Protein.Strategic partnerships grow from the ground up 🌱 | Mindaugas Lazdauskas
  BIORRO, represented by Mindaugas Lazdauskas, hosted Cosun Protein for field visits and talks about a potential €75–100 million wet faba bean protein isolate facility in Lithuania, signaling active collaboration and potential growth in the local pulse farming …
• 2025-11-27 Kartu su kolegomis iš Panevėžio aruodas komandos šiandien dalyvavome Agroverslas 2025 konferencijoje, daug realių įžvalgų, tiesiai iš sektoriaus lyderių. | Mindaugas Lazdauskas
  BIORRO is represented by Mindaugas Lazdauskas, who serves on the Management Board (2 years 6 months in that role) and previously was CEO; he is based in Kaunas, Lithuania.
• 2026-09-03 €61 Million Cell Therapy Center Opens in Vilnius — Another Step in the “Bio City” Vision – LithuaniaBIO
  BIORRO is not mentioned in the article. The piece focuses on the €61 million Cell Therapy Center in Vilnius as part of the Bio City III project, its capabilities (cell therapy, personalized vaccines, regenerative medicine, 3D-printed tissues), expected 100 …
• 2026-09-03 Lithuania Opens €61 Million BIO CITY III Cell Therapy Centre | Lithuania
  BIORRO is not mentioned in the article. The piece focuses on Lithuania inaugurating the €61 million BIO CITY III cell therapy and personalised medicine centre in Vilnius, its capabilities (20 GMP-compliant production lines, 3,500 sq m, CAR-T and 3D tissue …
• 2026-09-23 Lithuania’s biotech ecosystem is moving from research towards scale, with companies working across the value chain – from AI-powered protein design and single-cell analysis to CRISPR, advanced therapies and precision fermentation.
  Summary: The article highlights Lithuania’s biotech shift from research to scalable industry, profiling five companies (Biomatter, Atrandi Biosciences, Caszyme, Northway Biotech, and Pentasweet) as examples of the broader ecosystem; BIORRO is not mentioned in …
• 2026-09-03 Lithuania is no longer just a consumer of global life sciences innovation. We're becoming its creators. 🧬
  BIORRO isn’t mentioned in this post. The update highlights Lithuania’s shift from consumer to creator in life sciences, celebrating the opening of BIO CITY III and the country’s biotech talent and ambition.

股权与投资方 1

同类企业

c-LEcta GmbH · AB Enzymes · Enzym Group · BIO-GEN · Solyve · Fermentia Ltd. · Leiber GmbH · INTERMAG